Mazaki-Tovi, Shali <br/><br/>
Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?  [electronic resource] 

 -  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians  Aug 2010 
 - 857-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1476-4954 
<br/><br/><label>Standard No.: </label>10.3109/14767050903301017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cross-Sectional Studies<br/>Cytokines--blood<br/>Female<br/>Fetal Growth Retardation--blood<br/>Humans<br/>Infant, Newborn<br/>Infant, Small for Gestational Age<br/>Nicotinamide Phosphoribosyltransferase--blood<br/>Phenotype<br/>Pre-Eclampsia--blood<br/>Pregnancy<br/>Young Adult